Scienmag

FEBRUARY 19, 2021

Anaylsis shows different genetic risk landscape for IBD In African Americans, the genetic risk landscape for inflammatory bowel disease (IBD) is very different from that of people with European ancestry, according to results of the first whole-genome study of IBD in African Americans.

Genome 50

Genome Genomics Genetics Clinical Research 50

Scienmag

SEPTEMBER 15, 2020

15, 2020 — Initial findings reported by the Arizona COVID-19 Genomics Union (ACGU) suggest that following Arizona’s first reported case of COVID-19 in late January, the state experienced no cases that went undetected […]. — Sept.

Genome 40

Genome Genomics Allergies Genetics 40

XTalks

MARCH 18, 2024

By genetically editing microorganisms, scientists can now manipulate the metabolic pathways to produce foods with desirable properties. The precision fermentation study highlights how genetically engineered microorganisms can inhibit the growth of foodborne pathogens.

Genetic Engineering 52

Genetic Engineering Genetics Production Protein 52

Scienmag

NOVEMBER 25, 2020

The analysis of virus genomes from over 46,000 people with COVID-19 from 99 countries is published today in Nature Communications. First and corresponding author Dr Lucy van Dorp (UCL Genetics […].

Genome 58

Genome Genomics Genetics Research 58

Scienmag

JUNE 22, 2021

A new study published in Genetic Epidemiology has examined the genetic code of SARS-CoV-2 viruses that have infected patients, looking for links between different mutations and patient deaths. For the study, investigators analyzed 7,548 SARS-CoV-2 genomes of COVID-19 patients worldwide […].

Genetics 40

Genetics Genome Genomics Research 40

The Pharma Data

DECEMBER 17, 2020

But Forbes, an assistant professor of pediatrics, immunology, allergy and rheumatology at Baylor College of Medicine in Houston, said the patient’s diabetes appears to have been reversed. This patient had a genetic mutation that ruxolitinib is known to work on. It’s in a class of medications known as JAK inhibitors.

Insulin 52

Insulin Genetics Doctors Doctor 52

The Pharma Data

FEBRUARY 22, 2021

Thanks to its R&D agreement with Pairwise , the Broad Institute and others, Bayer has access to the best genome editing tools. Bayer’s research collaboration with the French biotech company Meiogenix is also accelerating the development of proprietary technologies related to plant breeding and genome editing applications.

Gene Editing 40

Gene Editing Genome Genomics Protein 40